Drawing for ILUNIA

USPTO serial 79460020

ILUNIA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with ILUNIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Computer program [software] for treating polycystic ovary syndrome (PCOS) and polyendocrine metabolic ovarian syndrome (PMOS) featuring medical information and content; software for conveying scientific content; computer software, namely interactive software for patients and medical professionals for the indication of polycystic ovary syndrome (PCOS) and polyendocrine metabolic ovarian syndrome (PMOS).ACTIVE—
041Providing training for users in medical fields with the aid of software; entertainment by means of Al-based conversational communication system.ACTIVE—
042Development of computer programs and software for the presentation of scientific data and for engaging in a dialogue including artificial intelligence; scientific research.ACTIVE—
044Medical services for computer-based interactive support for patients and medical professionals in the field of the treatment of polycystic ovary syndrome (PCOS) and polyendocrine metabolic ovarian syndrome (PMOS).ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 20, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 8, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance